Practical Applications of Mitochondria Research
in Space and Extreme Medicine
Exclusive online event
Conference Agenda
Time: Thursday, June 10th 2021, 5 pm BST - 7:45 pm BST
5:00 - 5:10: Kate Batz (Managing Partner, Longevity.Capital), Franco Cortese (Director, Aging Analytics Agency)
Opening Remarks
5:10 - 5:30: Dmitry Kaminskiy (General Partner, Deep Knowledge Group)SpaceTech, FemTech and The Future of Reproductive Longevity on Earth and Beyond
5:30 - 5:50: Dr. Arkadi Prokopov
The Untold History and Present State of Space Medicine and Practical Human Longevity
5:50 - 6:05: Dr. Michael Zemel (Chief Scientific Officer, NuSirt BioPharma)
TBD
6:05 - 6:20: Dr. James Carroll (Chief Executive Officer, Thor)
TBD
6:20 - 6:35: Dr. Thomas Seoh (Chief Executive Officer, Kinexum)
TBD
6:35 - 6:50: David Brown, Ph.D., Senior Director, Scientific and Technical Innovation at Stealth BioTherapeutics
TBD
6:50 - 6:55: Kate Batz (Managing Partner, Longevity.Capital), Franco Cortese (Director, Aging Analytics Agency)
Introduction to Panel Discussion
6:55 - 7:35: Panel Discussion
7:35 - 7:45: Kate Batz (Managing Partner, Longevity.Capital), Franco Cortese (Director, Aging Analytics Agency)
Closing Remarks
Speakers
Dr. Thomas Seoh
Chief Executive Officer at Kinexum
Thomas Seoh is an entrepreneur/executive who has held senior leadership positions in public and private, pharmaceutical, biotech and medical device companies for over 25 years. After practicing corporate law in New York and London and serving as General Counsel for several companies, including Viratek in Costa Mesa, which developed the antiviral, VIRAZOLE®, and engaged in antisense oligonucleotide research, he joined Guilford Pharmaceuticals in Baltimore, which commercialized GLIADEL® wafer for glioblastoma multiforme and developed the propofol pro-drug LUSEDRA® and small molecules for Parkinson’s disease. Thomas began as Guilford's VP, General Counsel and Secretary, and later served as SVP Corporate and Commercial Development. Thomas holds an AB in Philosophy and History and a JD from Harvard University.